We conducted a genome-wide association study among 2,323 individuals with sporadic amyotrophic lateral sclerosis (ALS) and 9,013 control subjects and evaluated all SNPs with P < 1.0 × 10−4 in a second, independent cohort of 2,532 affected individuals and 5,940 controls. Analysis of the genome-wide data revealed genome-wide significance for one SNP, rs12608932, with P = 1.30 × 10−9. This SNP showed robust replication in the second cohort (P = 1.86 × 10−6), and a combined analysis over the two stages yielded P = 2.53 × 10−14. The rs12608932 SNP is located at 19p13.3 and maps to a haplotype block within the boundaries of UNC13A, which regulates the release of neurotransmitters such as glutamate at neuromuscular synapses. Follow-up of additional SNPs showed genome-wide significance for two further SNPs (rs2814707, with P = 7.45 × 10−9, and rs3849942, with P = 1.01 × 10−8) in the combined analysis of both stages. These SNPs are located at chromosome 9p21.2, in a linkage region for familial ALS with frontotemporal dementia found previously in several large pedigrees.
Subscribe to Journal
Get full journal access for 1 year
only $17.42 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Rent or Buy article
Get time limited or full article access on ReadCube.
All prices are NET prices.
Mitchell, J.D. & Borasio, G.D. Amyotrophic lateral sclerosis. Lancet 369, 2031–2041 (2007).
Miller, R.G., Mitchell, J.D., Lyon, M. & Moore, D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst. Rev. CD001447 (2007).
Graham, A.J., Macdonald, A.M. & Hawkes, C.H. British motor neuron disease twin study. J. Neurol. Neurosurg. Psychiatry 62, 562–569 (1997).
van Es, M.A. et al. Genetic variation in DPP6 is associated with susceptibility to amyotrophic lateral sclerosis. Nat. Genet. 40, 29–31 (2008).
van Es, M.A. et al. ITPR2 as a susceptibility gene in sporadic amyotrophic lateral sclerosis: a genome-wide association study. Lancet Neurol. 6, 869–877 (2007).
Dunckley, T. et al. Whole-genome analysis of sporadic amyotrophic lateral sclerosis. N. Engl. J. Med. 357, 775–788 (2007).
Cronin, S. et al. A genome-wide association study of sporadic ALS in a homogenous Irish population. Hum. Mol. Genet. 17, 768–774 (2008).
Chio, A. et al. A two-stage genome-wide association study of sporadic amyotrophic lateral sclerosis. Hum. Mol. Genet. 18, 1524–1532 (2009).
Schymick, J.C. et al. Genome-wide genotyping in amyotrophic lateral sclerosis and neurologically normal controls: first stage analysis and public release of data. Lancet Neurol. 6, 322–328 (2007).
Landers, J.E. et al. Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA 106, 9004–9009 (2009).
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
Pe'er, I., Yelensky, R., Altshuler, D. & Daly, M.J. Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet. Epidemiol. 32, 381–385 (2008).
The International HapMap Consortium. The International HapMap Project. Nature 426, 789–796 (2003).
Varoqueaux, F., Sons, M.S., Plomp, J.J. & Brose, N. Aberrant morphology and residual transmitter release at the Munc13-deficient mouse neuromuscular synapse. Mol. Cell. Biol. 25, 5973–5984 (2005).
Augustin, I., Rosenmund, C., Sudhof, T.C. & Brose, N. Munc13–1 is essential for fusion competence of glutamatergic synaptic vesicles. Nature 400, 457–461 (1999).
Phukan, J., Pender, N.P. & Hardiman, O. Cognitive impairment in amyotrophic lateral sclerosis. Lancet Neurol. 6, 994–1003 (2007).
Raaphorst, J., De, V.M., Linssen, W.H., De Haan, R.J. & Schmand, B. The cognitive profile of amyotrophic lateral sclerosis: a meta-analysis. Amyotroph. Lateral Scler. published online, doi:10.1080/17482960802645008 (29 January 2009).
Valdmanis, P.N. et al. Three families with amyotrophic lateral sclerosis and frontotemporal dementia with evidence of linkage to chromosome 9p. Arch. Neurol. 64, 240–245 (2007).
Morita, M. et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia. Neurology 66, 839–844 (2006).
Vance, C. et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2–21.3. Brain 129, 868–876 (2006).
Stefansson, H. et al. Large recurrent microdeletions associated with schizophrenia. Nature 455, 232–236 (2008).
Hofman, A. et al. The Rotterdam Study: objectives and design update. Eur. J. Epidemiol. 22, 819–829 (2007).
Kiemeney, L.A. et al. Sequence variant on 8q24 confers susceptibility to urinary bladder cancer. Nat. Genet. 40, 1307–1312 (2008).
Krawczak, M. et al. PopGen: population-based recruitment of patients and controls for the analysis of complex genotype-phenotype relationships. Community Genet. 9, 55–61 (2006).
Wichmann, H.E., Gieger, C. & Illig, T. KORA-gen–resource for population genetics, controls and a broad spectrum of disease phenotypes. Gesundheitswesen 67 Suppl 1, S26–S30 (2005).
Schmermund, A. et al. Assessment of clinically silent atherosclerotic disease and established and novel risk factors for predicting myocardial infarction and cardiac death in healthy middle-aged subjects: rationale and design of the Heinz Nixdorf RECALL Study. Risk Factors, Evaluation of Coronary Calcium and Lifestyle. Am. Heart J. 144, 212–218 (2002).
Luca, D. et al. On the use of general control samples for genome-wide association studies: genetic matching highlights causal variants. Am. J. Hum. Genet. 82, 453–463 (2008).
Need, A.C. et al. A genome-wide investigation of SNPs and CNVs in schizophrenia. PLoS Genet. 5, e1000373 (2009).
Brooks, B.R. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial “Clinical limits of amyotrophic lateral sclerosis” workshop contributors. J. Neurol. Sci. 124 Suppl, 96–107 (1994).
de Bakker, P.I. et al. Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum. Mol. Genet. 17, R122–R128 (2008).
Barrett, J.C., Fry, B., Maller, J. & Daly, M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263–265 (2005).
Johnson, A.D. et al. SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24, 2938–2939 (2008).
Gabriel, S.B. et al. The structure of haplotype blocks in the human genome. Science 296, 2225–2229 (2002).
We thank the individuals and their families who participated in this project; the study staff, general practitioners and pharmacists; P. Arp, M. Jhamai, M. Moorhouse, M. Verkerk and S. Bervoets for their help in creating the GWAS database; D.B. Goldstein for his contribution to the genotyping and analysis of the control sample from the German schizophrenia study; and N. Freimer for critical comments and reading of the manuscript. This project was supported by the Prinses Beatrix Fonds, VSB fonds, H. Kersten and M. Kersten (Kersten Foundation), The Netherlands ALS Foundation, and J.R. van Dijk and the Adessium Foundation (L.H.v.d.B.). J.H.V. was supported by the Brain Foundation of The Netherlands. The generation and management of GWAS genotype data for the Rotterdam Study was supported by The Netherlands Organisation for Scientific Research (NWO) investments (no. 175.010.2005.011, 911-03-012), the Research Institute for Diseases in the Elderly (RIDE; 014-93-015) and the Netherlands Genomics Initiative/NWO (project no. 050-060-810). The controls from the Dutch schizophrenia GWAS were genotyped with the support of the National Institute for Mental Health (R.A.O.). The Rotterdam study was funded by Erasmus Medical Center and Erasmus University, Rotterdam; the Netherlands Organization for Health Research and Development; RIDE; the Ministry of Education, Culture and Science; the Ministry for Health, Welfare and Sports; the European Commission (DG XII); and the Municipality of Rotterdam. The Irish studies were funded by the Muscular Dystrophy Association USA (S.C., O.H.), the Health Research Board of Ireland (O.H.) and the Irish Motor Neuron Disease Research Foundation. In Sweden, this project was supported by the Swedish Brain Research Foundation, the Hållstens Research Foundation, the Swedish Medical Society, the Björklund Foundation for ALS Research and the Swedish Association for the Neurologically Disabled (P.M.A.). W.R. was supported through the E. von Behring Chair for Neuromuscular and Neurodegenerative Disorders and by the Interuniversity Attraction Poles program P6/43 of the Belgian Federal Science Policy Office. The Polish study was partially funded by the Polish Ministry of Science and Higher Education (nos. N N402 083934 and N402 092 32/3216). In France, this study was funded by the Association pour la Recherche sur la SLA and the Association Réseau SLA Ile de France. We thank the Motor Neurone Disease Association of Great Britain and Ireland, the Medical Research Council (UK), the Wellcome Trust and the Psychiatry Research Trust (Tim Perkins Fund and Charcot Fund). Support was also provided by the ALS Therapy Alliance, Project ALS, the Angel Fund, the Pierre L. de Bourgknecht ALS Research Foundation, the Al-Athel ALS Research Foundation, the ALS Family Charitable Foundation and the National Institute of Neurological Disorders and Stroke (NS050557). R.H.B. is a cofounder of AviTx, which targets development of therapies.
About this article
Cite this article
van Es, M., Veldink, J., Saris, C. et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis. Nat Genet 41, 1083–1087 (2009). https://doi.org/10.1038/ng.442
European Journal of Human Genetics (2021)
Searching Far and Genome-Wide: The Relevance of Association Studies in Amyotrophic Lateral Sclerosis
Frontiers in Neuroscience (2021)
Association of Single Nucleotide Polymorphism at rs2275294 in the ZNF512B Gene with Prognosis in Amyotrophic Lateral Sclerosis
NeuroMolecular Medicine (2021)
Neurobiology of Disease (2021)
EMBO Molecular Medicine (2021)